Skip to main content
OpenTrials

Clinical trial condition

Thyroid Diseases

Explore clinical trials studying Thyroid Diseases. Study availability and eligibility vary by location and protocol.

1,049 public trials 244 recruiting studies
Refine in advanced search Browse all conditions

Thyroid Diseases trial results

Active, Not Recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

NCT04951219

Conditions
Digestive System Diseases, Dyslipidemias, Endocrine System Diseases, +14 more
Locations
  • Central Research Associates Birmingham, Alabama, United States
  • Arizona Liver Health - Chandler Chandler, Arizona, United States
  • East Valley Family Physicians Chandler, Arizona, United States
  • The Institute For Liver Health - Glendale Glendale, Arizona, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

NCT06812325

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Catalina Eye Care Tuscon, Arizona, United States
  • United Medical Research Institute Inglewood, California, United States
  • Orbital Plastics Newport Beach, California, United States
  • California Eye Specialists Medical Group INC Pasadena, California, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

NCT06625398

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Scottsdale Clinical Trials Scottsdale, Arizona, United States
  • Alliance Research Institute - Canoga Park Canoga Park, California, United States
  • Marvel Clinical Research Huntington Beach, California, United States
  • United Medical Research Institute Inglewood, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

NCT06106828

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Plastics-Orbit-Neuro San Diego, California, United States
  • Connecticut Eye Consultants, P.C. Danbury, Connecticut, United States
  • University of Illinois Eye and Ear Infirmary Chicago, Illinois, United States
  • Scheie Eye Institute Philadelphia, Pennsylvania, United States
View all 40 locations
View Trial Details
Active, Not Recruiting

IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

NCT01398085

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +13 more
Locations
  • Belfast Health and Social Care Trust Belfast, United Kingdom
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • University Hospitals Sussex NHS Foundation Trust Brighton, United Kingdom
  • University Hospital Bristol NHS Foundation Trust Bristol, United Kingdom
View all 36 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

NCT05987423

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations
  • Thrive Health Research LLC Beverly Hills, California, United States
  • UCSD Shiley Eye Center La Jolla, California, United States
  • Grene Vision Group, LLC Wichita, Kansas, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 46 locations
View Trial Details

Related conditions